Mercado mundial de la dermatitis: tendencias de la industria y pronóstico hasta 2029

Análisis y tamaño del mercado

En los últimos años, se prevé que el mercado de la dermatitis crezca rápidamente durante el período de pronóstico. La dermatitis atópica afecta aproximadamente a 31,6 millones de personas en los Estados Unidos según la red de alergia y asma de 2020. La dermatitis atópica afecta al 15-20 por ciento de los niños y al 1-3 por ciento de los adultos en todo el mundo. Además, el estilo de vida en constante cambio da como resultado el uso creciente de cosméticos, cremas faciales, protector solar y pasta de dientes fluorada. Junto con esto, la tasa de prevalencia de enfermedades crónicas o relacionadas con el estilo de vida es alta, incluido el uso creciente de esteroides tópicos e inhalados. Estos son los factores causales que aumentan el riesgo de dermatitis. Por lo tanto, esto llevó a la alta demanda de dermatitis en el mercado.

Data Bridge Market Research analiza que el mercado de la dermatitis se valoró en USD 5.92 mil millones en 2021 y se espera que alcance los USD 11.04 mil millones para 2029, registrando una CAGR del 8,10% durante el período de pronóstico de 2022 a 2029. El informe de mercado curado por el equipo de Data Bridge Market Research incluye un análisis experto en profundidad, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Definición de mercado

La dermatitis es un término que abarca una variedad de enfermedades, incluida la inflamación de la piel. En la mayoría de las personas, las primeras etapas de la dermatitis se caracterizan por piel roja, seca y con picazón. La dermatitis más grave puede causar escamas costrosas, grietas dolorosas o ampollas llenas de líquido. Debido a que numerosos elementos pueden irritar la piel, un médico intentará limitar el diagnóstico a un tipo específico de dermatitis, aunque la mayoría de los tipos de irritación e inflamación de la piel tienen tratamientos similares.

Alcance del informe y segmentación del mercado

Dermatitis Market Dynamics

Drivers

• Surging prevalence rate of allergic reactions

The rising prevalence of allergic reactions, with food allergies playing a prominent role is estimated to enhance the dermatitis market's growth. According to a 2020 report from the Food Allergy Research and Education, 32 million Americans have food allergies, including 5.6 million children under the age of 18. Approximately 40% of children with food allergies are allergic to many foods.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of dermatitis market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

• Growing number of geriatric population

The surging geriatric population is estimated to enhance the market's expansion during the forecast period of 2022-2029. According to the World Health Organization (WHO), the worldwide geriatric population, which was estimated to be over 524 million in 2010, is expected to increase to nearly 2 billion by 2050. Due to their compromised immune systems, geriatrics are more susceptible to get chronic ailments, further estimated to enhance the market's growth rate.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the dermatitis market. Additionally, increasing environmental pollution and rising incidences of hormonal imbalances will expand the dermatitis market.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the dermatitis market growth. Along with this, rising drug approvals and launches will further propel the market's growth rate. 

Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will provide beneficial opportunities for the dermatitis market growth during the forecast period.

Restraints/Challenges

On the other hand, high cost high cost associated with the treatment will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the dermatitis market. Additionally, strict regulatory policies and lack of awareness among people will restrain and further impede the growth rate of the market during the forecast period of 2022-2029.

This dermatitis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the dermatitis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Dermatitis market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Dermatitis Market

Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. Due to the financial crisis and the delay in specialty healthcare delivery while prioritizing COVID-19-related treatments, healthcare systems were severely disrupted in the aftermath of the coronavirus pandemic. Patients were unable to see their controls for a variety of reasons, including difficulty accessing a doctor, fear of infection transmission, inability to continue therapies and essential procedures due to pandemic restrictions. Such considerations had a negative impact on the market of dermatitis in recent months.

Recent Development

• In May 2020, Sanofi had announced the U.S. Food and Drug Administration (FDA) approval for Dupixent (dupilumab). It is approved as a first biologic medicine for children aged 6 to 11 years suffering from moderate-to-severe atopic dermatitis. When compared to TCS alone, Dupixent + topical corticosteroids (TCS) resulted in more than twice as many children having clear or nearly clear skin and more than four times as many children having itch relief in the crucial trial. Three-quarters of Dupixent patients saw a 75 percent or greater improvement in total illness, with an average improvement of around 80 percent.

Global Dermatitis Market Scope

The dermatitis market is segmented on the basis of type, treatment, diagnosis, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Contact Dermatitis
• Atopic Dermatitis
• Diaper Dermatitis
• Nummular Dermatitis
• Dyshidrotic Dermatitis
• Perioral Dermatitis
• Neurodermatitis
• Seborrheic Dermatitis
• Stasis Dermatitis

Treatment

• Antibiotics
• Antihistamines
• Calcineurin Inhibitors
• Topical Corticosteroids
• Emollients
• Topical Antiseptic
• Others

Diagnosis

• Blood Tests
• Allergy Skin Test
• Skin Biopsy

Dosage form

• Tablets
• Ointments
• Others

Route of Administration

• Oral
• Topical
• Others

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Dermatitis Market Regional Analysis/Insights

The dermatitis market is analyzed and market size insights and trends are provided by country, type, treatment, diagnosis, dosage form, route of administration, end-users and distribution channel as referenced above.

The countries covered in the dermatitis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the perioral dermatitis treatment market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and well-developed healthcare infrastructure in this region.

Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period of 2022-2029 due to the increasing cases of dermatitis diseases and rising investment in the healthcare sector. Also, growing government support and rising level of disposable income will propel the market's growth rate.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Dermatitis Market Share Analysis

The dermatitis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to dermatitis market.

Some of the major players operating in the dermatitis market are:

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (US)
• Teva Pharmaceutical Industries Ltd.(Israel)
• Sanofi (France), Pfizer Inc. (US)
• GlaxoSmithKline plc (UK)
• Novartis AG (Switzerland)
• AstraZeneca (UK)
• Johnson & Johnson (US)
• Bayer AG (Germany)
• Sun Pharmaceutical Industries Ltd. (India)
• LEO Pharma A/S (Denmark)
• Aurobindo Pharma (India)
• Lupin (India)
• Eli Lilly and Company (US)
• Boehringer Ingelheim International GmbH. (Germany)
• Bausch Health Companies Inc. (Canada)
• Bristol-Myers Squibb Company (US)
• AbbVie Inc. (Estados Unidos)
• Allergan (Irlanda)

SKU-54103